Ingredients

Kojic acid: the fermented brightener with a sensitisation problem

Close-up of fresh green rosemary sprigs with water droplets.

TL;DR

Kojic acid is a fungal fermentation byproduct (Aspergillus oryzae) that inhibits tyrosinase like alpha arbutin and hydroquinone do. It works. It also has the highest contact sensitisation rate in the brightening category, with patch-test failure rates near 5 percent. Concentrations above 2 percent and chronic daily use are the main triggers.

Kojic acid keeps coming up in K-beauty and Japanese skincare. The story is appealing: fermented from rice koji, the same fungus used in sake brewing, a natural-feeling alternative to hydroquinone. The story is also incomplete. Kojic acid has a sensitisation profile that the marketing rarely talks about.

What kojic acid actually does

Kojic acid is a chelating compound produced by Aspergillus and Penicillium fungi during fermentation. In skincare, it inhibits tyrosinase by binding to the copper ion at the enzyme’s active site. No active tyrosinase, no new melanin production, fading of existing pigment as cell turnover progresses.

Mechanically, this is the same tyrosinase pathway that alpha arbutin and hydroquinone target. The difference is potency and side-effect profile. Kojic acid sits between the two: more aggressive than alpha arbutin, gentler than hydroquinone, but with its own specific risk that the other two do not share. Postbiotic skincare covers fermented ingredients more broadly.

The real numbers, both directions

A 1996 Dermatologic Therapy paper found 4 percent kojic acid reduced melasma pigmentation by 51 percent over 12 weeks. That is genuinely strong. A 2002 follow-up at 2 percent showed 38 percent reduction over the same period.

The other side: a 2010 European Journal of Dermatology paper looked at patch-test data from 1,128 patients tested for cosmetic contact allergens. Kojic acid produced positive reactions in 4.7 percent of subjects, which placed it among the higher-sensitising cosmetic ingredients alongside fragrances and certain preservatives. The 2018 update to that data, reviewed by the European Scientific Committee on Consumer Safety, set the safe topical limit at 1 percent for leave-on products.

So kojic acid works, and it sensitises skin more than its competitors. Both things are true.

The contrarian section: fermented does not mean gentle

There is a marketing narrative in K-beauty and Japanese skincare that fermented ingredients are inherently gentler because they are derived from traditional food processes. Kojic acid is the cleanest counter-example. It is fermented. It sensitises a meaningful fraction of users. The two facts are unrelated.

The same logic applies to galactomyces and Saccharomyces ferments at high concentrations: “natural” and “fermented” do not predict tolerability. The chemistry of the molecule predicts tolerability. Five words: fermented is not auto-safe.

If you have sensitive skin or a history of contact dermatitis to skincare, kojic acid should be near the bottom of your brightening shortlist, not near the top.

Who should try it

Stubborn melasma that did not respond to alpha arbutin or niacinamide. Post-inflammatory hyperpigmentation that has lingered for over six months. Skin that has tolerated hydroquinone in the past without issue. People who patch-tested kojic acid first and showed no reaction.

Who should skip it: reactive skin, rosacea, eczema-prone, anyone in the middle of barrier repair, anyone using a retinoid for the first six weeks. Pregnancy is generally considered low risk but kojic acid is one of the brighteners where I would specifically check with an obstetrician.

How to use it without sensitising

Start at 1 to 2 percent. Use three nights a week, not nightly. Apply after cleansing and a hydrating layer, before moisturizer. SPF 50 daily, non-negotiable.

Watch for the early sensitisation signal: a mild itch or warmth that does not subside in five minutes. That is the precursor to a real reaction. Stop immediately. Wait two weeks. Try a different brightener.

The pair I see work clinically: kojic acid 1 percent plus alpha arbutin 2 percent plus tranexamic acid 3 percent, three nights a week. The combination targets three points on the melanin pathway and lets you use each at a lower individual dose. Tranexamic acid vs hydroquinone covers the broader brightening hierarchy.

The honest case for using it anyway

For melasma that has not budged after six months of gentler treatment, kojic acid is one of the few escalations available without going to a prescription tyrosine kinase inhibitor or hydroquinone under supervision. The risk is real but quantifiable. A patch test, a controlled introduction, and a backup plan are usually enough to use it safely.

I have used 2 percent kojic acid myself for a stretch of fourteen weeks targeting a stubborn post-acne mark. It worked. I also stopped at exactly fourteen weeks because chronic use is where the sensitisation risk compounds. Adjacent reads sit under hyperpigmentation and sensitive.

How to spot it on a label

INCI name: kojic acid, or kojic dipalmitate (the more stable derivative used at higher concentrations because it is less reactive). Kojic dipalmitate has a milder sensitisation profile but is also less effective on a per-percent basis. A 4 percent kojic dipalmitate product is roughly equivalent to a 1.5 percent pure kojic acid product.

FAQ

Is kojic acid safe in pregnancy? Check with your obstetrician. It is one of the brighteners where the data is less reassuring than alpha arbutin.

Can I use it with vitamin C? Yes, but introduce them on different weeks to isolate any reaction.

How long until I see results? Four to eight weeks for visible change. Twelve weeks for meaningful fading.

Should I patch test? Always, especially with this ingredient. How to patch test covers the protocol.

What if I develop a reaction? Stop immediately, switch to alpha arbutin or niacinamide, and let the skin reset for at least two weeks before reintroducing any brightener.

Sources: PubMed / Dermatologic Therapy (1996) on kojic acid in melasma; European Scientific Committee on Consumer Safety (2018) opinion on kojic acid.